Abstract
Colorectal cancer (CRC) is the third most common cancer diagnosed worldwide making it a serious global challenge. CRC progression results from dysregulated cytoplasmic transcription factors, including signal transducer and activator of transcription (STAT) proteins that are involved in JAK-STAT pathway. The STAT proteins contain a conserved SH2 domain that facilitates the initiation of STAT activation via binding to tyrosine motifs followed by STAT dimerization. The STAT proteins include STAT1, STAT2 and STAT3 which all facilitate therapeutic targets for many drugs, since they are associated with pathogenesis in various cancers such as CRC. Genistein is an efficient chemopreventive phytochemical drug against CRC. The current investigation presents a computational study performed to investigate the molecular interaction between STAT1, STAT2 and STAT3 proteins with genistein. The molecular dynamic simulation was conducted for STAT2 protein. The studies from molecular docking revealed that the interaction of STAT proteins and genistein is predicted to be effective with better binding energies. Furthermore, targeting STAT3 could be an efficient therapeutic target and understanding the interaction between STAT3 and genistein can help to contribute to a better inhibition process for CRC progression. Treatment with genistein led to significant suppression of cell proliferation and STAT3 protein expression in both CRC (HCT 116 and HT-29) cell lines. This further provides development of efficient STAT inhibitors with better potency and bioavailability.
Similar content being viewed by others
Abbreviations
- CRC:
-
Colorectal cancer
- MDS:
-
Molecular dynamic simulation
- MM:
-
Molecular mechanics
- NMR:
-
Nuclear magnetic resonance
- PDB:
-
Protein data bank
- RMSD:
-
Root mean square deviation
- RMSF:
-
Root mean square fluctuation
- STAT:
-
Signal transducer and activator of transcription
References
Albai O, Frandes M, Timar B, Paun DL, Roman D, Timar R (2020) Long-term risk of malignant neoplastic disorders in type 2 diabetes mellitus patients with metabolic syndrome. Diabetes Metab Syndr Obes 13:1317–1326. https://doi.org/10.2147/DMSO.S243263
Liu K, Lai M, Wang S, Zheng K, Xie S, Wang X (2020) Construction of a CXC chemokine-based prediction model for the prognosis of colon cancer. Biomed Res Int 2020:6107865. https://doi.org/10.1155/2020/6107865
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB (2019) Colorectal cancer. Lancet 394:1467–1480. https://doi.org/10.1016/S0140-6736(19)32319-0
Laissue P (2019) The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis. Mol Cancer 18:5. https://doi.org/10.1186/s12943-019-0938-x
Zhao Y, Hu X, Zuo X, Wang M (2018) Chemopreventive effects of some popular phytochemicals on human colon cancer: a review. Food Funct 9:4548–4568. https://doi.org/10.1039/c8fo00850g
Afrin S, Giampieri F, Gasparrini M, Forbes-Hernandez TY, Cianciosi D, Reboredo-Rodriguez P, Zhang J, Manna PP, Daglia M, Atanasov AG, Battino M (2020) Dietary phytochemicals in colorectal cancer prevention and treatment: a focus on the molecular mechanisms involved. Biotechnol Adv 38:107322. https://doi.org/10.1016/j.biotechadv.2018.11.011
Lee DY, Yun SM, Song MY, Jung K, Kim EH (2020) Cyanidin chloride induces apoptosis by inhibiting NF-kappaB signaling through activation of Nrf2 in colorectal cancer cells. Antioxidants (Basel). https://doi.org/10.3390/antiox9040285
Darnell JE Jr (1997) STATs and gene regulation. Science 277:1630–1635. https://doi.org/10.1126/science.277.5332.1630
Zhang J, Ahn KS, Kim C, Shanmugam MK, Siveen KS, Arfuso F, Samym RP, Deivasigamanim A, Lim LH, Wang L, Goh BC, Kumar AP, Hui KM, Sethi G (2016) Nimbolide-induced oxidative stress abrogates STAT3 signaling cascade and inhibits tumor growth in transgenic adenocarcinoma of mouse prostate model. Antioxid Redox Signal 24:575–589. https://doi.org/10.1089/ars.2015.6418
Loh CY, Arya A, Naema AF, Wong WF, Sethi G, Looi CY (2019) Signal transducer and activator of transcription (STATs) proteins in cancer and inflammation: functions and therapeutic implication. Front Oncol 9:48. https://doi.org/10.3389/fonc.2019.00048
Tanaka A, Zhou Y, Ogawa M, Shia J, Klimstra DS, Wang JY, Roehrl MH (2020) STAT1 as a potential prognosis marker for poor outcomes of early stage colorectal cancer with microsatellite instability. PLoS ONE 15:e0229252. https://doi.org/10.1371/journal.pone.0229252
Gamero AM, Young MR, Mentor-Marcel R, Bobe G, Scarzello AJ, Wise J, Colburn NH (2010) STAT2 contributes to promotion of colorectal and skin carcinogenesis. Cancer Prev Res (Phila) 3:495–504. https://doi.org/10.1158/1940-6207.CAPR-09-0105
Masuda M, Suzui M, Yasumatu R, Nakashima T, Kuratomi Y, Azuma K, Tomita K, Komiyama S, Weinstein IB (2002) Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res 62:3351–3355
Benekli M, Xia Z, Donohue KA, Ford LA, Pixley LA, Baer MR, Baumann H, Wetzler M (2002) Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival. Blood 99:252–257. https://doi.org/10.1182/blood.v99.1.252
Horiguchi A, Oya M, Shimada T, Uchida A, Marumo K, Murai M (2002) Activation of signal transducer and activator of transcription 3 in renal cell carcinoma: a study of incidence and its association with pathological features and clinical outcome. J Urol 168:762–765
Corvinus FM, Orth C, Moriggl R, Tsareva SA, Wagner S, Pfitzner EB, Baus D, Kaufmann R, Huber LA, Zatloukal K, Beug H, Ohlschlager P, Schutz A, Halbhuber KJ, Friedrich K (2005) Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia 7:545–555
Zhou P, Wang C, Hu Z, Chen W, Qi W, Li A (2017) Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1/NF-kappaB/slug/E-cadherin pathway. BMC Cancer 17:813. https://doi.org/10.1186/s12885-017-3829-9
Guex N, Peitsch MC (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18:2714–2723
Dariya B, Behera SK, Srivani G, Farran B, Alam A, Nagaraju GP (2020) Computational analysis of nuclear factor-κB and resveratrol in colorectal cancer. J Biomol Struct Dynam. https://doi.org/10.1080/07391102.2020.1757511
Chiu SW, Pandit SA, Scott HL, Jakobsson E (2009) An improved united atom force field for simulation of mixed lipid bilayers. J Phys Chem B 113:2748–2763
Kaistha SD, Sinha R (2009) Homology modeling of phosphoryl thymidine kinase of enterohemorrhagic Escherichia coli OH: 157. Bioinformation 3(6):240–243
Xiong A, Yang Z, Shen Y, Zhou J, Shen Q (2014) Transcription factor STAT3 as a novel molecular target for cancer prevention. Cancers (Basel) 6:926–957. https://doi.org/10.3390/cancers6020926
van Waalwijk van Doorn-Khosrovani SB, Janssen J, Maas LM, Godschalk RW, Nijhuis JG, van Schooten FJ (2007) Dietary flavonoids induce MLL translocations in primary human CD34+ cells. Carcinogenesis 28:1703–1709
Treeck O, Lattrich C, Springwald A, Ortmann O (2010) Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells. Breast Cancer Res Treat 120:557–565
Jiang Y, Gong P, Madak-Erdogan Z, Martin T, Jeyakumar M, Carlson K, Khan I, Smillie TJ, Chittiboyina AG, Rotte SC (2013) Mechanisms enforcing the estrogen receptor β selectivity of botanical estrogens. FASEB J 27:4406–4418
Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC (2004) Estrogen receptor β inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Can Res 64:423–428
Jiang X, Patterson NM, Ling Y, Xie J, Helferich WG, Shapiro DJ (2008) Low concentrations of the soy phytoestrogen genistein induce proteinase inhibitor 9 and block killing of breast cancer cells by immune cells. Endocrinology 149:5366–5373
Kumi-Diaka J, Rodriguez R, Goudaze G (1998) Influence of genistein (4′, 5, 7-trihydroxyisoflavone) on the growth and proliferation of testicular cell lines. Biol Cell 90:349–354
Spector LG, Xie Y, Robison LL, Heerema NA, Hilden JM, Lange B, Felix CA, Davies SM, Slavin J, Potter JD (2005) Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children's oncology group. Cancer Epidemiol Prev Biomarkers 14:651–655
Azarova AM, Lin R-K, Tsai Y-C, Liu LF, Lin C-P, Lyu YL (2010) Genistein induces topoisomerase IIbeta-and proteasome-mediated DNA sequence rearrangements: implications in infant leukemia. Biochem Biophys Res Commun 399:66–71
Chang HC, Doerge DR (2000) Dietary genistein inactivates rat thyroid peroxidase in vivo without an apparent hypothyroid effect. Toxicol Appl Pharmacol 168:244–252
Doerge DR, Sheehan DM (2002) Goitrogenic and estrogenic activity of soy isoflavones. Environ Health Perspect 110:349–353
Divi RL, Chang HC, Doerge DR (1997) Anti-thyroid isoflavones from soybean: isolation, characterization, and mechanisms of action. Biochem Pharmacol 54:1087–1096
Ebmeier CC, Anderson RJ (2004) Human thyroid phenol sulfotransferase enzymes 1A1 and 1A3: activities in normal and diseased thyroid glands, and inhibition by thyroid hormones and phytoestrogens. J Clin Endocrinol Metab 89:5597–5605
Brahmbhatt S, Brahmbhatt RM, Boyages SC (2000) Thyroid ultrasound is the best prevalence indicator for assessment of iodine deficiency disorders: a study in rural/tribal schoolchildren from Gujarat (Western India). Eur J Endocrinol 143:37–46
Tuli HS, Tuorkey MJ, Thakral F, Sak K, Kumar M, Sharma AK, Sharma U, Jain A, Aggarwal V, Bishayee A (2019) Molecular mechanisms of action of genistein in cancer: recent advances. Front Pharmacol 10:1336. https://doi.org/10.3389/fphar.2019.01336
Zhou P, Wang C, Hu Z, Chen W, Qi W, Li A (2017) Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1/NF-κB/slug/E-cadherin pathway. BMC Cancer 17:1–10
Singh-Gupta V, Zhang H, Banerjee S, Kong D, Raffoul JJ, Sarkar FH, Hillman GG (2009) Radiation-induced HIF-1alpha cell survival pathway is inhibited by soy isoflavones in prostate cancer cells. Int J Cancer 124:1675–1684. https://doi.org/10.1002/ijc.24015
Russo M, Russo GL, Daglia M, Kasi PD, Ravi S, Nabavi SF, Nabavi SM (2016) Understanding genistein in cancer: the “good” and the “bad” effects: a review. Food Chem 196:589–600
Qi W, Weber CR, Wasland K, Savkovic SD (2011) Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity. BMC Cancer 11:1–9
Zhang Z, Wang C-Z, Du G-J, Qi L-W, Calway T, He T-C, Du W, Yuan C-S (2013) Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells. Int J Oncol 43:289–296
Lee CK, Bluyssen HA, Levy DE (1997) Regulation of interferon-alpha responsiveness by the duration of Janus kinase activity. J Biol Chem 272:21872–21877. https://doi.org/10.1074/jbc.272.35.21872
Hamalainen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E (2007) Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm 2007:45673. https://doi.org/10.1155/2007/45673
Meng XY, Zhang HX, Mezei M, Cui M (2011) Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided Drug Des 7:146–157. https://doi.org/10.2174/157340911795677602
Platanias LC (2005) Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 5:375–386. https://doi.org/10.1038/nri1604
Antonczyk A, Krist B, Sajek M, Michalska A, Piaszyk-Borychowska A, Plens-Galaska M, Wesoly J, Bluyssen HAR (2019) Direct inhibition of IRF-dependent transcriptional regulatory mechanisms associated with disease. Front Immunol 10:1176. https://doi.org/10.3389/fimmu.2019.01176
Wen Z, Zhong Z, Darnell JE Jr (1995) Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241–250. https://doi.org/10.1016/0092-8674(95)90311-9
Wen Z, Darnell JE Jr (1997) Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3. Nucleic Acids Res 25:2062–2067. https://doi.org/10.1093/nar/25.11.2062
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dariya, B., Muppala, S., Srivani, G. et al. Targeting STAT proteins via computational analysis in colorectal cancer. Mol Cell Biochem 476, 165–174 (2021). https://doi.org/10.1007/s11010-020-03893-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-020-03893-6